...
首页> 外文期刊>Urologic oncology >Life after failure of traditional androgen deprivation therapy
【24h】

Life after failure of traditional androgen deprivation therapy

机译:传统雄激素剥夺疗法失败后的生活

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Castrate resistant prostate cancer is a disease state which, counterintuitively, can be successfully treated with additional therapy directed at inhibition of androgen synthesis and/or interfering with the activity of the androgen receptor. Novel androgen biosynthesis inhibitors and antiandrogens are now being tested in large phase 3 clinical trials to clarify their role in the treatment of men who have failed traditional medical castration, with or without currently available nonsteroidal antiandrogens. A renewed interest in studying parenteral delivery of estrogens may provide evidence to revisit the initial medical therapy for advancing prostate cancer.
机译:与直觉相反,去势抵抗性前列腺癌是可以通过针对抑制雄激素合成和/或干扰雄激素受体活性的其他疗法成功治疗的疾病状态。新型雄激素生物合成抑制剂和抗雄激素现在正在大型3期临床试验中进行测试,以阐明其在治疗传统药物去势失败的男性中的作用,无论是否使用目前可用的非甾体类抗雄激素。对研究胃肠外递送雌激素的重新兴趣可能提供证据,以重新审视用于推进前列腺癌的初始药物治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号